# Andre Esteva

Principales episodios de podcast
Actualizado:

SEASON 3, EPISODE 13 - Andre Esteva, PhD - Personalizing Treatment Decisions through Artificial Intelligence

Today we are discussing how treatment decisions can be personalized through artificial intelligence and digital pathology. Our guest is Andre Esteva of Artera. Atera’s first product is in prostate cancer. We discuss how AI can improve upon the current state of the practice which largely relies …

Google’s Exploration of Large Language Models in Medicine

Large language models (LLMs) like ChatGPT have proven highly capable of a broad array of natural language tasks including summarizing text, generating prose, and answering questions. This episode’s two guests, Dr. Alan Karthikesalingam and Vivek Natarajan of Google, describe their team’s recent eff…

21 - Deep Learning - Regularization Part 5 2020

<p>Deep Learning - Regularization Part 5</p> <p>This video discusses multi-task learning.</p> <p>Video References:<br /> <a href="https://www.youtube.com/channel/UCSHZKyawb77ixDdsGog4iWA">Lex Fridman&#39;s Channel</a></p> <p>Further Reading:<br /> <a href="https://www.sciencedirect.com/science/a…

Your smartphone could soon be a powerful tool for detecting skin cancer

They’ll be some of the weirder selfies you’ve ever taken, but a study using artificial intelligence to analyze images of skin lesions suggests that smartphones may soon help humans detect skin cancer. Published today in Nature, the study began with an unremarkable image-recognition network provided…

R25 Section 5 - General Imaging

Papers discussed in this Section 5 Podcast: Andre Esteva, Brett Kuprel, Roberto A. Novoa, Justin Ko, Susan M. Swetter, Helen M. Blau & Sebastian Thrun. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115–118 (02 February 2017) doi:10.1038/nature21056 Gulsha…

Using AI-Powered Diagnostics to Identify Optimal Therapies for Prostate Cancer with Andre Esteva Artera TRANSCRIPT

Andre Esteva is the CEO and Co-Founder of Artera, a company focused on improving prostate cancer diagnostics. The company uses an AI-driven test, validated in large-scale clinical trials, to analyze a tumor biopsy or surgical specimen and predict response to therapy and likely long-term outcomes. …

Using AI-Powered Diagnostics to Identify Optimal Therapies for Prostate Cancer with Andre Esteva Artera

Andre Esteva is the CEO and Co-Founder of Artera, a company focused on improving prostate cancer diagnostics. The company uses an AI-driven test, validated in large-scale clinical trials, to analyze a tumor biopsy or surgical specimen and predict response to therapy and likely long-term outcomes. …

How This MedTech Startup Is Transforming Prostate Cancer Care with AI | Interview with Artera CEO

In this exclusive interview, discover how Artera, a pioneering MedTech startup, is harnessing AI to revolutionize prostate cancer treatment and reshape the future of personalized medicine. Join me, Dr. Roupen—a physician and oncologist passionate about healthcare innovation—as I chat with Artera’s …

Deep Learning - Regularization Part 5

Deep Learning - Regularization Part 5 This video discusses multi-task learning. Further Reading: A gentle Introduction to Deep Learning Links: Link - for details on Maximum A Posteriori estimation and the bias-variance decomposition Link - for a comprehensive text about practical recommenda…

Modernizing Healthcare with AI

[Monty2026: AI at the Frontlines of Medicine] Mel van Londen (Co-Founder & CEO, Develop Health), Anan Kashyap (CFO, Hippocratic AI), and Andre Esteva (Co-Founder & CEO, ArteraAI) discuss healthcare AI adoption with moderator Katya Andresen (SVP & Chief Digital & Analytics Officer, The Cigna Group)…